SCHEMBL7369663

SCHEMBL7369663

O=[N+]([O-])C1=CCC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2043925 0.79
SCHEMBL2085607 0.62
SCHEMBL2937547 0.61
SCHEMBL7265390 0.59
SCHEMBL2043928 0.58
SCHEMBL2039514 0.58
SCHEMBL21315696 0.56
SCHEMBL2049520 0.56
SCHEMBL2042953 0.56
SCHEMBL21363782 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000031-A4 VITRONECTIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORP (US) 2001-08-16 EP disclosed
US-6239138-B1 TREATMENT OF INFLAMMATION, CANCER, CARDIOVASCULAR DISORDERS, SUCH AS ATHEROSCLEROSIS AND RESTENOSIS, OSTEOPOROSIS, BENZOCYCLOHEPTENYL IN WHICH A NITROGEN-CONTAINING SUBSTITUENT IS PRESENT ON THE AROMATIC SIX-MEMBERED RING AND AN ALIPHATIC SMITHKLINE BEECHAM CORPORATION 2001-05-29 US disclosed
EP-1000031-A1 VITRONECTIN RECEPTOR ANTAGONIST SmithKline Beecham Corporation (US) 2000-05-17 EP disclosed
WO-1999005107-A1 VITRONECTIN RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORPORATION (US) 1999-02-04 WO disclosed
EP-0002208-B1 NITRO 1,4-DIHYDROPYRIDINES, MEDICAMENTS CONTAINING THEM AND THEIR MANUFACTURE BAYER AG (DE) 1981-03-11 EP disclosed
EP-0002208-A1 Nitro 1,4-dihydropyridines, medicaments containing them and their manufacture BAYER AG (DE) 1979-06-13 EP disclosed